{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:15:24Z","timestamp":1783401324703,"version":"3.54.6"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007514","name":"University of Pisa","doi-asserted-by":"publisher","award":["549901_2023"],"award-info":[{"award-number":["549901_2023"]}],"id":[{"id":"10.13039\/501100007514","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.numecd.2025.104373","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T07:53:15Z","timestamp":1758700395000},"page":"104373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effect of bempedoic acid on incretin axis and systemic and liver inflammation: a pilot, monocentric study"],"prefix":"10.1016","volume":"36","author":[{"given":"Chiara","family":"Rovera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Del Zoppo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Petralli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Moriconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariarosaria","family":"Distaso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizia Rossana","family":"Brunetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ele","family":"Ferrannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Raggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7855-8253","authenticated-orcid":false,"given":"Anna","family":"Solini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2025.104373_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13457","article-title":"Liver-specific ATP-citrate lyase inhibition by bempedoic acid decreases LDL-C and attenuates atherosclerosis","volume":"7","author":"Pinkosky","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.numecd.2025.104373_bib2","first-page":"71","article-title":"Bempedoic acid: how will it shape the future lipid-lowering landscape? Mode of action","volume":"149","author":"Drexel","year":"2024","journal-title":"Evidence Clin Use Cardiol"},{"key":"10.1016\/j.numecd.2025.104373_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjcard.2022.03.020","article-title":"Long-Term safety and efficacy of bempedoic acid in patients with atherosclerotic cardiovascular disease and\/or heterozygous familial hypercholesterolemia (from the CLEAR harmony open-label extension study)","volume":"174","author":"Ballantyne","year":"2022","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.numecd.2025.104373_bib4","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1056\/NEJMoa2215024","article-title":"CLEAR outcomes investigators. Bempedoic acid and cardiovascular outcomes in statin-intolerant patients","volume":"388","author":"Nissen","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2025.104373_bib5","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1080\/14796678.2024.2388478","article-title":"Risk of cardiovascular outcomes with bempedoic acid in high-risk statin intolerant patients: a systematic review and meta-analysis","volume":"20","author":"Hamayal","year":"2024","journal-title":"Future Cardiol"},{"key":"10.1016\/j.numecd.2025.104373_bib6","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/joim.13824","article-title":"Effect on C-reactive protein levels of the addition of ezetimibe, bempedoic acid, or colchicine to statin treatment: a network meta-analysis","volume":"296","author":"Xie","year":"2024","journal-title":"J Intern Med"},{"key":"10.1016\/j.numecd.2025.104373_bib7","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s40264-020-00931-6","article-title":"Effect of bempedoic acid on serum uric acid and related outcomes: a systematic review and meta-analysis of the available phase 2 and phase 3 clinical studies","volume":"43","author":"Cicero","year":"2020","journal-title":"Drug Saf"},{"key":"10.1016\/j.numecd.2025.104373_bib8","doi-asserted-by":"crossref","first-page":"e566","DOI":"10.1097\/MJT.0000000000001715","article-title":"Efficacy and safety of bempedoic acid for prevention of adverse cardiovascular events and diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials","volume":"31","author":"Yasmin","year":"2024","journal-title":"Am J Therapeut"},{"key":"10.1016\/j.numecd.2025.104373_bib9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ceb.2017.01.005","article-title":"AMPK signalling in health and disease","volume":"45","author":"Carling","year":"2017","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.numecd.2025.104373_bib10","first-page":"1","article-title":"Lipid clinic experience with bempedoic acid in three UK centres","author":"Jakubowska","year":"2024","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.numecd.2025.104373_bib11","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1056\/NEJMoa1803917","article-title":"CLEAR harmony trial. Safety and efficacy of bempedoic acid to reduce LDL cholesterol","volume":"380","author":"Ray","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2025.104373_bib12","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/jamacardio.2020.2314","article-title":"Association of bempedoic acid administration with atherogenic lipid levels in phase 3 randomized clinical trials of patients with hypercholesterolemia","volume":"5","author":"Banach","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.numecd.2025.104373_bib13","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/cpt.1307","article-title":"A model-based meta-analysis of 24 antihyperglycemic drugs for type 2 diabetes: Comparison of treatment effects at therapeutic doses","volume":"105","author":"Maloney","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.numecd.2025.104373_bib14","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/dom.14645","article-title":"Bempedoic acid in patients with type 2 diabetes mellitus, prediabetes, and normoglycaemia: a post hoc analysis of efficacy and glycaemic control using pooled data from phase 3 clinical trials","volume":"24","author":"Leiter","year":"2022","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.numecd.2025.104373_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109392","article-title":"Bempedoic acid, an ATP citrate lyase inhibitor, reduces intimal hyperplasia via activation of AMPK\u03b1 signaling pathway","volume":"113","author":"Liu","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.numecd.2025.104373_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121963","article-title":"Targeting the adenosine monophosphate-activated protein kinase signalling pathway by bempedoic acid attenuates angiotensin II-induced cardiac remodelling in renovascular hypertension in rats","volume":"329","author":"Ahmed","year":"2023","journal-title":"Life Sci"},{"key":"10.1016\/j.numecd.2025.104373_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.1028355","article-title":"Mechanism of action and therapeutic use of bempedoic acid in atherosclerosis and metabolic syndrome","volume":"9","author":"Biolo","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.numecd.2025.104373_bib18","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1194\/jlr.M300368-JLR200","article-title":"Insulin resistance is associated with increased cholesterol synthesis and decreased cholesterol absorption in normoglycemic men","volume":"45","author":"Pihlajam\u00e4ki","year":"2004","journal-title":"J Lipid Res"},{"key":"10.1016\/j.numecd.2025.104373_bib19","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1440-1746.2011.06704.x","article-title":"SREBP-2: a link between insulin resistance, hepatic cholesterol, and inflammation in NASH","volume":"26","author":"Van Rooyen","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.numecd.2025.104373_bib20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/hep4.1801","article-title":"Role of cholesterol-associated steatohepatitis in the development of NASH","volume":"6","author":"Horn","year":"2021","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.numecd.2025.104373_bib21","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.metabol.2016.02.014","article-title":"Molecular mechanisms of lipotoxicity and glucotoxicity in non-alcoholic fatty liver disease","volume":"65","author":"Mota","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.numecd.2025.104373_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2024.10.014","article-title":"Bempedoic acid suppresses diet-induced hepatic steatosis independently of ATP-Citrate lyase","volume":"37","author":"Liu","year":"2025","journal-title":"Cell Metab"},{"key":"10.1016\/j.numecd.2025.104373_bib23","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.3748\/wjg.v30.i39.4324","article-title":"Recent developments in non-invasive methods for assessing metabolic dysfunction-associated fatty liver disease","volume":"30","author":"Singh","year":"2024","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.numecd.2025.104373_bib24","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jacl.2023.02.002","article-title":"Effects of bempedoic acid on CRP, IL-6, fibrinogen and lipoprotein(a) in patients with residual inflammatory risk: a secondary analysis of the CLEAR harmony trial","volume":"17","author":"Ridker","year":"2023","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.numecd.2025.104373_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.991393","article-title":"Association between inflammatory markers and non-alcoholic fatty liver disease in obese children","volume":"10","author":"Duan","year":"2022","journal-title":"Front Public Health"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475325005277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475325005277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T14:19:03Z","timestamp":1773152343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475325005277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0939475325005277"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2025.104373","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of bempedoic acid on incretin axis and systemic and liver inflammation: a pilot, monocentric study","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2025.104373","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104373"}}